Home
/
Sagimet Biosciences Inc.
/
Financials
/
Quarterly
Sagimet Biosciences Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Sagimet Biosciences Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2023
$2.00M
Nov 14, 2024
Q3
2023
Jul 31, 2023
$2.00M
Nov 13, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($12.91M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($10.39M)
Aug 13, 2025
Q3
2025
Jun 30, 2025
($10.39M)
Nov 13, 2025
Q3
2025
Mar 31, 2025
($18.18M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($18.18M)
May 8, 2025
Q2
2025
Mar 31, 2025
($18.18M)
Aug 13, 2025
Q3
2025
Sep 30, 2024
($14.62M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($8.12M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($8.12M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($6.63M)
May 8, 2025
Q2
2025
Mar 31, 2024
($6.63M)
Aug 13, 2025
Q3
2025
Mar 31, 2024
($6.63M)
Nov 13, 2025
Q3
2024
Sep 30, 2023
($6.35M)
Nov 14, 2024
Q3
2024
Jun 30, 2023
($6.79M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($6.79M)
Aug 14, 2024
Q2
2024
Mar 31, 2023
($6.59M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($6.59M)
May 15, 2024
Q3
2024
Mar 31, 2023
($6.59M)
Nov 14, 2024
Q3
2023
Sep 30, 2022
($7.47M)
Nov 13, 2023
Q3
2023
Jun 30, 2022
($7.10M)
Nov 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($14.33M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($11.93M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($19.87M)
May 8, 2025
Q3
2025
Sep 30, 2024
($16.90M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($10.59M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($8.77M)
May 8, 2025
Q3
2024
Sep 30, 2023
($7.45M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($7.06M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($6.77M)
May 15, 2024
Q3
2023
Sep 30, 2022
($7.69M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($7.24M)
Aug 21, 2023